订阅小程序
旧版功能

415P Patterns of Time-to-progression Intervals Across Clinical and Liquid Biopsy (LB) Features in Hormone Receptor-Positive (HR+) HER2-negative (HER2-) Metastatic Breast Cancer (MBC) Patients (pts) Treated with First-Line Endocrine Therapy (ET)

Annals of Oncology(2023)

引用 0|浏览5
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要